Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 255

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Resistin, Adiponectin, and Risk of Heart Failure

Open access
Frankel, David S., Vasan, Ramachandran S., D'Agostino, Ralph B., Benjamin, Emelia J., Levy, Daniel, Wang, Thomas J., Meigs, James B.·2009·Journal of the American College of Cardiology

Abstract

Objective We tested the association of the adipokines resistin and adiponectin with incident heart failure. Background Abnormal concentrations of adipokines may partially explain the association between obesity and heart failure. Methods We related circulating adipokine concentrations to the incidence of heart failure in 2,739 participants in the Framingham Offspring Study. Results During six years of follow-up, 58 participants developed new-onset heart failure. In proportional hazards models (adjusting for age, sex, blood pressure, antihypertensive treatment, diabetes, smoking, total/HDL cholesterol ratio, prevalent coronary heart disease, valvular heart disease, left ventricular hypertrophy and estimated glomerular filtration rate) using the lowest third of the resistin distribution as the referent, the hazard ratios (HRs) for heart failure in the middle and top thirds were 2.89 (95% confidence interval 1.05–7.92) and 4.01 (1.52–10.57), respectively (P=0.004 for trend). Additional adjustment for body mass index, insulin resistance (measured with the homeostasis model), C-reactive protein and B-type natriuretic peptide did not substantively weaken this association (multivariable HRs 2.62 and 3.74, P=0.007). In the maximally-adjusted model, each standard deviation increment in resistin (7.45 ng/ml) was associated with a 26% increase in heart failure risk (95% CI -1–60%). Concentrations of adiponectin were not associated with heart failure (multivariable HRs 0.87 and 0.97, P=0.9). Conclusions Elevated circulating concentrations of resistin were associated with incident heart failure, even after accounting for prevalent coronary heart disease, obesity, and for measures of insulin resistance and inflammation. The findings suggest a role for resistin in human disease and a novel pathway to heart failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2008.07.073

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 255

Metadata

Authors
Frankel, D. S., Vasan, R. S., D'Agostino, R. B., Benjamin, E. J., Levy, D., Wang, T. J., & Meigs, J. B.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2009-03
Volume
53
Issue
9
Pages
754-762
ISSN
0735-1097 (ISSN-L)
OpenAlex
W57547456
Cited by
255
References
13
FWCI
15.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resistin, Adiponectin, and Risk of Heart Failure. https://app.cochat.ai/papers/10.1016/j.jacc.2008.07.073
The paper
Frankel, D. S., Vasan, R. S., D'Agostino, R. B., Benjamin, E. J., Levy, D., Wang, T. J., & Meigs, J. B. (2009). Resistin, Adiponectin, and Risk of Heart Failure. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2008.07.073

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.